Surveillance Imaging Modalities for Breast Cancer Assessment
SIMBA
Comparative Effectiveness of Surveillance Modalities in Breast Cancer Survivors
1 other identifier
observational
36,444
0 countries
N/A
Brief Summary
The purpose of this study is to determine the effectiveness of surveillance breast MRI compared to mammography alone in women with a personal history of breast cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2013
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 21, 2014
CompletedFirst Posted
Study publicly available on registry
August 8, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedResults Posted
Study results publicly available
February 7, 2017
CompletedAugust 22, 2024
July 1, 2024
3.1 years
March 21, 2014
November 28, 2016
July 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Breast Cancers Detected
Number of second breast cancers detected in the 12 months after surveillance mammogram or breast MRI
12 months post surveillance exam
Study Arms (2)
Mammograms
Surveillance mammograms in women with a personal history of breast cancer
Breast MRI
Surveillance breast Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer
Eligibility Criteria
Surveillance imaging exams in women included in the Breast Cancer Surveillance Consortium who are 18+ years of age at the the of a Stage 0-III incident breast cancer diagnosis between January 1, 2005 and December 31, 2012.
You may not qualify if:
- Women with a diagnosis of lobular carcinoma in situ
- Women with missing cancer staging data from Surveillance, Epidemiology and End Results (SEER) Program records
- Women with Stage 4 breast cancer at time of diagnosis
- Women with a diagnosis of a second breast cancer event within six months of the primary diagnosis
- Women who die within six months of primary diagnosis
- Women who have had a double mastectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- Dartmouth Collegecollaborator
- Harvard Pilgrim Health Carecollaborator
- University of North Carolina, Chapel Hillcollaborator
- University of California, San Franciscocollaborator
- University of Wisconsin, Madisoncollaborator
- Patient-Centered Outcomes Research Institutecollaborator
Related Publications (3)
Johnson DS, Bush MT, Brandzel S, Wernli KJ. The patient voice in research-evolution of a role. Res Involv Engagem. 2016 Feb 22;2:6. doi: 10.1186/s40900-016-0020-4. eCollection 2016.
PMID: 29062507BACKGROUNDHenderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med. 2019 Oct;34(10):2098-2106. doi: 10.1007/s11606-019-05181-6. Epub 2019 Aug 13.
PMID: 31410813BACKGROUNDWernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 Aug;292(2):311-318. doi: 10.1148/radiol.2019182475. Epub 2019 Jun 4.
PMID: 31161975RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This study was not a clinical trial. It was a cohort analysis of existing data.
Results Point of Contact
- Title
- Karen J. Wernli, PhD
- Organization
- Group Health Research Institute
Study Officials
- PRINCIPAL INVESTIGATOR
Karen J. Wernli, PhD
Group Health Research Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2014
First Posted
August 8, 2014
Study Start
October 1, 2013
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
August 22, 2024
Results First Posted
February 7, 2017
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share